| 000 | 01580 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512092237.0 | ||
| 264 | 0 | _c19750905 | |
| 008 | 197509s 0 0 eng d | ||
| 022 | _a0022-3956 | ||
| 024 | 7 |
_a10.1016/0022-3956(74)90079-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAndén, N E | |
| 245 | 0 | 0 |
_aAntipsychotic drugs and catecholamine synapses. Summary of the session. _h[electronic resource] |
| 260 |
_bJournal of psychiatric research _c1974 |
||
| 300 |
_a97-104 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntipsychotic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBasal Ganglia Diseases _xprevention & control |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 |
_aButyrophenones _xpharmacology |
| 650 | 0 | 4 |
_aCatecholamines _xmetabolism |
| 650 | 0 | 4 |
_aCorpus Striatum _xmetabolism |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 | _aDopamine Antagonists |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLimbic System _xmetabolism |
| 650 | 0 | 4 |
_aMethyltyrosines _xpharmacology |
| 650 | 0 | 4 |
_aNorepinephrine _xmetabolism |
| 650 | 0 | 4 |
_aParasympatholytics _xpharmacology |
| 650 | 0 | 4 | _aPhenothiazines |
| 650 | 0 | 4 | _aReceptors, Drug |
| 650 | 0 | 4 |
_aReceptors, Neurotransmitter _xmetabolism |
| 650 | 0 | 4 |
_aReserpine _xpharmacology |
| 650 | 0 | 4 |
_aSubstantia Nigra _xmetabolism |
| 650 | 0 | 4 |
_aSynapses _xmetabolism |
| 650 | 0 | 4 | _aSynaptic Transmission |
| 773 | 0 |
_tJournal of psychiatric research _gvol. 11 _gp. 97-104 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0022-3956(74)90079-x _zAvailable from publisher's website |
| 999 |
_c4162230 _d4162230 |
||